Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VER-01 in Chronic Non-specific Low Back Pain
NCT04940741Phase 3Completed
- Sponsor
- Vertanical
- Start
- Jul 2021
- Primary completion
- Mar 2024
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of VER-01 in chronic low back pain (CLBP), sponsored by Vertanical. Started Jul 2021; status: completed.
02
Drugs
VER-01
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT04940741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04940741.